Tetra-cyclic carboline derivatives for inhibiting angiogenesis

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/14 (2006.01) A61K 31/437 (2006.01)

Patent

CA 2559545

In accordance with the present invention,tetracyclic caboline derivatives that inhibit the expression of VEGF post-transcriptionally have been identified, and methods for their use provided. In one aspect of the invention, these compounds useful in the inhibition of VEGF production, in the inhibition of angiogenesis, and/or in the treatment of cancer, diabetic retinopathy or exudative macular degeneration are provided. In another aspect of the invention, methods are provided for the inhibition of VEGF production, the inhibition of angiogenesis, and/or the treatment of cancer, diabetic retinopathy or exudative macular degeneration using the compounds of the invention.

Selon l'invention, des composés qui inhibent l'expression de VEGF après transcription, ont été identifiés, et l'invention a pour objet des procédés pour les utiliser. Un aspect de l'invention concerne des composés utiles pour inhiber la production de VEGF, pour inhiber l'angiogenèse, et/ou pour traiter le cancer, la rétinopathie diabétique ou la dégénérescence maculaire exsudative. Un autre aspect de l'invention concerne des procédés pour inhiber la production de VEGF, inhiber l'angiogenèse et/ou traiter le cancer, la rétinopathie diabétique ou la dégénérescence maculaire exsudative au moyen desdits composés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Tetra-cyclic carboline derivatives for inhibiting angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tetra-cyclic carboline derivatives for inhibiting angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetra-cyclic carboline derivatives for inhibiting angiogenesis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1460392

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.